Clinical Trial Update: Effect of Omacor on Triglycerides in HIV Infected Subjects [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports the terminated study evaluating Omacor on triglyceride levels in HIV-infected subjects with hypertriglyceridemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hypertriglyceridemia

Drugs mentioned

• Omacor (omega-3-acid ethyl esters)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Hyper-Triglyceridemia | Phase 4 | Status: TERMINATED